Hepatitis C and the limits of medicalisation and biological citizenship for people who inject drugs

ISSN： 1606-6359

Source： Addiction Research and Theory, Vol.18, Iss.5, 2010-10, pp. : 544-556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for hepatitis C

By Soriano Vincent Madejon Antonio Vispo Eugenia Labarga Pablo Garcia-Samaniego Javier Martin-Carbonero Luz Sheldon Julie Bottecchia Marcelle Tuma Paula Barreiro Pablo

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Drugs in Development for Hepatitis C

By Stauber Rudolf E.

Drugs, Vol. 68, Iss. 10, 2008-01 ,pp. : 1347-1359

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of new oral hepatitis C antiviral drugs

By Vispo Eugenia Barreiro Pablo Soriano Vicente

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 5-16

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for a Phantom Menace: Emerging Drugs for Hepatitis C

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 3, 2006-01 ,pp. : 8-13

Adis International

Access to resources Recommend Favorite

Drugs in Clinical Development for Hepatitis C: Summary and Table

Pharmaceutical Medicine, Vol. 25, Iss. 5, 2011-10 ,pp. : 319-329

Adis International

Access to resources Recommend Favorite